XNAS · Healthcare · Diagnostics & Research
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | Q1 2026 | — | -0.81 | — | $6.7M | — | -0.35% | -14.13% | -22.73% |
| 2026-03-30 | Q4 2025 | — | 0.34 | — | $6.7M | — | +0.00% | +8.73% | +24.71% |
| 2025-11-14 |
| Q3 2025 |
| — |
| -0.05 |
| — |
| $6.8M |
| — |
| — |
| — |
| — |
| 2025-08-13 | Q2 2025 | — | 0.05 | — | $5.7M | — | -0.35% | +1.75% | +36.46% |
| 2025-03-31 | Q4 2024 | — | -0.24 | — | $5.5M | — | +0.00% | -20.35% | +7.67% |
| 2024-08-13 | Q2 2024 | — | -0.83 | — | $4.4M | — | -1.59% | +22.43% | +19.81% |
| 2024-05-14 | Q1 2024 | -0.70 | -1.46 | -108.57% | $3.4M | ❌ Miss | -3.85% | -9.09% | -10.78% |
| 2024-03-29 | Q4 2023 | -0.93 | 0.88 | +194.62% | $4.3M | ✅ Beat | — | — | — |
Showing last 8 quarters.